GIM
PTCT icon

Granahan Investment Management’s PTC Therapeutics PTCT Stock Holding History

Granahan Investment Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-381,227
Closed -$12.4M – 228
2015
Q4 		$12.4M Buy
381,227
+145,127
+61% +$4.27M 0.42% 89
2015
Q3 		$6.3M Buy
236,100
+119,600
+103% +$5.12M 0.2% 163
2015
Q2 		$5.61M Buy
116,500
+11,500
+11% +$671K 0.16% 171
2015
Q1 		$6.39M Sell
105,000
-764,101
-88% -$46.6M 0.18% 161
2014
Q4 		$45M Sell
869,101
-10,501
-1% -$462K 1.31% 10
2014
Q3 		$38.7M Sell
879,602
-861
-0.1% -$26.9K 1.2% 17
2014
Q2 		$23M Sell
880,463
-20,960
-2% -$449K 0.67% 56
2014
Q1 		$23.6M Buy
+901,423
New +$24.2M 0.63% 64

Other funds holding PTCT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Granahan Investment Management's PTCT Position: Q1 2016 in Review

Granahan Investment Management sold out of PTC Therapeutics (PTCT) in Q1 2016, closing a stake of 381,227 shares — an estimated $12.4M sold.

Granahan Investment Management first reported a position in PTCT in Q1 2014 and held it in 8 quarters. The position peaked at $45M in Q4 2014. 119 funds tracked by Wall St. Rank hold PTCT as of Q1 2016.

  • Granahan Investment Management reported no remaining PTC Therapeutics position as of Q1 2016 after selling out during the quarter.
  • Granahan Investment Management sold 381,227 PTC Therapeutics shares in Q1 2016, an estimated $12.4M.
  • Granahan Investment Management first reported a position in PTC Therapeutics in Q1 2014 and held it in 8 quarters.
  • Granahan Investment Management's PTC Therapeutics position peaked at $45M in Q4 2014.
  • 119 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2016.

Based on Granahan Investment Management's 13F filing for Q1 2016, filed 13 May 2016.